Head-to-Head Trial in Relapsing MS

• by Kathryn Wighton

• July 7, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

In Vivo CAR T: A New Route to Treating Autoimmune Disease

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

• by Ying K. Tam, Sean Semple

• July 13, 2026

• 7 min

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

• April 6, 2026

• 3 min